Journal Basic Info

  • Impact Factor: 2.709**
  • H-Index: 11 
  • ISSN: 2474-1663
  • DOI: 10.25107/2474-1663
**Impact Factor calculated based on Google Scholar Citations. Please contact us for any more details.

Major Scope

  •  Immunology
  •  Kidney Cancer
  •  Targeted Therapy
  •  Palliative Care
  •  Melanoma/Skin Cancer
  •  Sarcomas
  •  Blood Cancer
  •  Haemato-Oncology

Abstract

Citation: Clin Oncol. 2017;2(1):1296.DOI: 10.25107/2474-1663.1296

Current Clinical Challenges and Emerging Multi-Modal Approaches for the Treatment of Pancreatic Cancer

Fiona Haxho, Manpreet Sambi, Bessi Qorri, William Harless and Myron R. Szewczuk


Department of Biomedical and Molecular Sciences, Queen’s University, Kingston, ON, Canada
ENCYT Technologies, Inc. Membertou, NS, Canada
These authors have contributed equally

*Correspondance to: William Harless Myron R. Szewczuk 

 PDF  Full Text Review Article | Open Access

Abstract:

Today, emerging therapies must effectively shut down multiple enabling characteristics that drive pancreatic cancer invasion and progression. These therapies include the concomitant suppression of growth factor signaling and anti-apoptotic pathways, immune-derived promoters of tumorigenesis, mechanisms of acquired drug resistance, as well as pro-metastatic signals that facilitate cancer cell migration and successful homing of disseminated tumor cells. Here, we provide an overview of some of the current treatment options available for patients with pancreatic cancer, as well as their limitations. Finally, we review some alternative multi-target strategies that may provide increased efficacy in cancer therapy.

Keywords:

Pancreatic cancer; PDAC; Cancer therapy; Drug resistance; Cancer stem cells; Alternative therapy

Cite the Article:

Haxho F, Sambi M, Qorri B, Harless W, Szewczuk MR. Current Clinical Challenges and Emerging Multi-Modal Approaches for the Treatment of Pancreatic Cancer. Clin Oncol. 2017; 2: 1296.

Search Our Journal

Journal Indexed In

Articles in PubMed

Metastatic Retroperitoneal Paraganglioma: Case Report and Review of the Literature
 PubMed  PMC  PDF  Full Text
LINGO-1 is a New Therapy Target and Biomarker for Ewing Sarcoma
 PubMed  PMC  PDF  Full Text
View More...

Articles with Grants

Outcome of Allogeneic Bone Marrow Transplantation for Acute Myeloid Leukemia Following Single Agent Induction with Hypomethylation
 PDF  Full Text
Examination of the Efficacy of Fulvestrant 500 mg Targeting Estrogen Receptor-Positive Postmenopausal Metastatic Breast Cancer: Prospective Observational Study (PerSeUS BC03 Study)
 Abstract  PDF  Full Text
View More...